156 related articles for article (PubMed ID: 19424681)
21. The action of a novel fluoroquinolone antibiotic agent antofloxacin hydrochloride on human-ether-à-go-go-related gene potassium channel.
Guo J; Han SN; Liu JX; Zhang XM; Hu ZS; Shi J; Zhang LR; Zhao ZZ; Zhang Z
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):643-9. PubMed ID: 20662825
[TBL] [Abstract][Full Text] [Related]
22. Blockade of human HERG K⁺ channels by rosiglitazone, an antidiabetic drug.
Lee SH; Sung MJ; Hahn SJ; Kim J; Min G; Jo SH; Choe H; Choi BH
Arch Pharm Res; 2012 Sep; 35(9):1655-64. PubMed ID: 23054723
[TBL] [Abstract][Full Text] [Related]
23. Effects of Na+ channel blocker, pilsicainide, on HERG current expressed in HEK-293 cells.
Wu LM; Orikabe M; Hirano Y; Kawano S; Hiraoka M
J Cardiovasc Pharmacol; 2003 Sep; 42(3):410-8. PubMed ID: 12960687
[TBL] [Abstract][Full Text] [Related]
24. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
[TBL] [Abstract][Full Text] [Related]
25. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
[TBL] [Abstract][Full Text] [Related]
26. Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells.
Lin K; Liu YQ; Xu B; Gao JL; Fu YC; Chen Y; Xue Q; Li Y
Acta Pharmacol Sin; 2013 Jun; 34(6):847-58. PubMed ID: 23524574
[TBL] [Abstract][Full Text] [Related]
27. Human Ether-à-go-go Related Gene (hERG) Channel Blocking Aporphine Alkaloids from Lotus Leaves and Their Quantitative Analysis in Dietary Weight Loss Supplements.
Grienke U; Mair CE; Saxena P; Baburin I; Scheel O; Ganzera M; Schuster D; Hering S; Rollinger JM
J Agric Food Chem; 2015 Jun; 63(23):5634-9. PubMed ID: 26035250
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.
Takemasa H; Nagatomo T; Abe H; Kawakami K; Igarashi T; Tsurugi T; Kabashima N; Tamura M; Okazaki M; Delisle BP; January CT; Otsuji Y
Br J Pharmacol; 2008 Feb; 153(3):439-47. PubMed ID: 17965736
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of Guanfu base A and Guanfu base G on HERG K+ channel.
Huang X; Yang Y; Zhu J; Xu D; Peng J; Liu J
J Cardiovasc Pharmacol; 2012 Jan; 59(1):77-83. PubMed ID: 21934630
[TBL] [Abstract][Full Text] [Related]
30. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel.
Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH
J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046
[TBL] [Abstract][Full Text] [Related]
31. Effect of daurisoline on HERG channel electrophysiological function and protein expression.
Liu Q; Mao X; Zeng F; Jin S; Yang X
J Nat Prod; 2012 Sep; 75(9):1539-45. PubMed ID: 22974355
[TBL] [Abstract][Full Text] [Related]
32. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
33. Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine.
Obers S; Staudacher I; Ficker E; Dennis A; Koschny R; Erdal H; Bloehs R; Kisselbach J; Karle CA; Schweizer PA; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2010 May; 381(5):385-400. PubMed ID: 20229012
[TBL] [Abstract][Full Text] [Related]
34. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
35. Effects of donepezil on hERG potassium channels.
Chae YJ; Lee HJ; Jeon JH; Kim IB; Choi JS; Sung KW; Hahn SJ
Brain Res; 2015 Feb; 1597():77-85. PubMed ID: 25498859
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cloned hERG potassium channels by risperidone and paliperidone.
Lee HJ; Choi JS; Choi BH; Hahn SJ
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):633-642. PubMed ID: 28265686
[TBL] [Abstract][Full Text] [Related]
37. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine.
Thurner P; Stary-Weinzinger A; Gafar H; Gawali VS; Kudlacek O; Zezula J; Hilber K; Boehm S; Sandtner W; Koenig X
J Pharmacol Exp Ther; 2014 Feb; 348(2):346-58. PubMed ID: 24307198
[TBL] [Abstract][Full Text] [Related]
39. The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels.
Tang Q; Li ZQ; Li W; Guo J; Sun HY; Zhang XH; Lau CP; Tse HF; Zhang S; Li GR
Br J Pharmacol; 2008 Oct; 155(3):365-73. PubMed ID: 18574455
[TBL] [Abstract][Full Text] [Related]
40. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]